The Multifaceted Role of Regulatory T Cells in Breast Cancer
Open accessThe DOI matches its Crossref record; 144 of the 145 references it cites were found in a registry or an index.
Abstract
The microenvironment of breast cancer hosts a dynamic cross talk between diverse players of the immune system. While cytotoxic immune cells are equipped to control tumor growth and metastasis, tumor-corrupted immunosuppressive immune cells strive to impair effective immunity and promote tumor progression. Of these, regulatory T cells (T regs), the gatekeepers of immune homeostasis, emerge as multifaceted players involved in breast cancer. Intriguingly, clinical observations suggest that blood and intratumoral T regs can have strong prognostic value, dictated by breast cancer subtype. Accordingly, emerging preclinical evidence shows that T regs occupy a central role in breast cancer initiation and progression and provide critical support to metastasis formation. Here, T regs are not only important for immune escape but also promote tumor progression independent of their immune regulatory capacity. Combining insights into T reg biology with advances made across the rapidly growing field of immuno-oncology is expected to set the stage for the design of more effective immunotherapy strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased presence of Tregs is linked to decreased patient survival in several types of malignancies [5–7].”
From Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review (2024) · cites this paper as [7]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109 · cited 1×
“Although survival rates for breast cancer patients are steadily increasing, it is still the leading cause of cancer-related deaths in women worldwide (Bray et al. 2018, DeSantis et al. 2019).”
BackgroundHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 1×
“The local niche within and surrounding tumors is collectively described as the tumor microenvironment (TME), which can profoundly impact the development and progression of cancer (Blomberg et al. 2018, Garner & de Visser 2020, Hanahan & Weinberg 2011).”
BackgroundPD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745 · cited 2×
“Further research showed that FOXP3 is the master transcription factor (TF) for the previously identified specialized immunosuppressive CD4+ CD25+ T lymphocytes, now known as Tregs (Fontenot et al. 2003, Hori et al. 2003).”
BackgroundUnderstanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145 · cited 1×
“This milieu is characterized by widespread expression of immune checkpoint receptors, inhibitory cytokines, hypoxia, and low levels of nutrients, all of which restrain the recruitment and function of cytotoxic immune cells (Binnewies et al. 2018).”
BackgroundRegulatory T Cells and Immune Tolerance
Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.009 · Cited by 5,325 · cited 1×
“…towards recognition of tissue-restricted selfantigens, which enable the suppression of immune responses directed towards host peptides upon activation via their TCRs ( Jordan et al. 2001, Kieback et al. 2016, Sakaguchi et al. 2008). www.annualreviews.org • Role of Tregs in Breast Cancer 293 A nn u.”
BackgroundAtezolizumab and nab-paclitaxel in advanced triple-negative breast cancer
Schmid, P., Adams, S., Rugo, H. S., Schneeweiss, A., Barrios, C. H., Iwata, H., Diéras, V., Hegg, R., Im, S.-A., Shaw Wright, G., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1809615 · Cited by 4,350
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
Vignali, D. A. A., Collison, L. W., & Workman, C. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2343 · Cited by 3,463
Research works printed but not linked: 2
- Peng GL, 2019, Am. J. Transl. Res., 11, 5039
- Wolf AM, 2003, Clin. Cancer Res., 9, 606
Cited by
Speiser, D. E., Chijioke, O., Schaeuble, K., & Münz, C. (2023) · Nature Cancer · doi:10.1038/s43018-023-00521-2 · Cited by 479
İmani, S., Farghadani, R., Roozitalab, G., Maghsoudloo, M., Emadi, M., Moradi, A., Abedi, B., & Kaboli, P. J. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03394-8 · Cited by 131
Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review
Li, Y., Zhang, C., Jiang, A., Lin, A., Liu, Z., Cheng, X., Wang, W., Cheng, Q., Zhang, J., Wei, T., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05104-y · Cited by 105
“Increased presence of Tregs is linked to decreased patient survival in several types of malignancies [5–7].”
BackgroundKos, K., Aslam, M. A., van de Ven, R., Wellenstein, M. D., Pieters, W., van Weverwijk, A., Duits, D. E. M., van Pul, K., Hau, C., Vrijland, K., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110447 · Cited by 60
Self-citationKos, K., Salvagno, C., Wellenstein, M. D., Aslam, M. A., Meijer, D. A., Hau, C., Vrijland, K., Kaldenbach, D., Raeven, E. A. M., Schmittnaegel, M., et al. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2063225 · Cited by 47
Self-citation
Metadata
- Authors
- Kos, K., & de Visser, K. E.
- Affiliations
- The Netherlands Cancer Institute (NL)
- Division of Tumor Biology and Immunology, Oncode Institute, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands;
- ORCID
- Kos, Kevin
- Venue
- Annual Review of Cancer Biology
- Publisher
- Annual Reviews
- Published
- 2021-03-04
- Volume
- 5
- Issue
- 1
- Pages
- 291-310
- ISSN
- 2472-3428 (ISSN-L)
- PMC
- PMC7611782
- OpenAlex
- W3111078720
- Cited by
- 58
- References
- 145
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 16 · 2023: 10 · 2022: 12 · 2021: 1
- FWCI
- 0.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Annual Review of Cancer Biology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion, cc-by)
- PubMed Central (acceptedVersion, cc-by)
- Leiden Repository (Leiden University) (submittedVersion, cc-by)
- Funders
- ZonMw (91819616)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (VICI 91819616, NWO-VICI91819616, 91819616)
- Oncode Institute
- FP7 Ideas: European Research Council (615300)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- regulatory T cells, breast cancer, tumor microenvironment, immunosuppression, tumor immune evasion, metastasis, breast cancer subtypes, prognostic factors, tumor progression, immunotherapy, immune homeostasis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Multifaceted Role of Regulatory T Cells in Breast Cancer. https://app.cochat.ai/papers/10.1146/annurev-cancerbio-042920-104912
- The paper
- Kos, K., & de Visser, K. E. (2021). The Multifaceted Role of Regulatory T Cells in Breast Cancer. Annual Review of Cancer Biology. https://doi.org/10.1146/annurev-cancerbio-042920-104912
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.